GAO Faults Corrective Action Reevaluation
Client Alert | less than 1 min read | 08.27.15
In eAlliant, LLC (Jan. 14, 2015), GAO demonstrated that reevaluations based on "corrective action" must independently pass muster. Here, the record contained no rational basis or explanation for why the official who had previously credited the protester's technical proposal with multiple strengths had allowed the removal of all but one strength during subsequent reevaluations when there were no material revisions to the RFP's technical requirements or to the protester's proposal.
Contacts
Insights
Client Alert | 3 min read | 03.02.26
Clinical trial sponsors and all other stakeholders involved in conducting commercial clinical trials of investigational medicinal products (IMP) in the UK.
Client Alert | 4 min read | 03.02.26
Client Alert | 3 min read | 02.27.26
Client Alert | 6 min read | 02.27.26
